These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6309318)

  • 1. Measurement of digitalis-like compound in plasma: application in studies of essential hypertension.
    Devynck MA; Pernollet MG; Rosenfeld JB; Meyer P
    Br Med J (Clin Res Ed); 1983 Sep; 287(6393):631-4. PubMed ID: 6309318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digitalis-like activity in human plasma: relation to blood pressure and sodium balance.
    Goto A; Yamada K; Ishii M; Sugimoto T
    Am J Med; 1990 Oct; 89(4):420-6. PubMed ID: 2220875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating digitalis-like compounds in essential hypertension.
    Devynck MA; Pernollet MG; Cloix JF; de The H; Kamal L; Elghozi JL; Rosenfeld J; Meyer P
    Clin Exp Hypertens A; 1984; 6(1-2):441-53. PubMed ID: 6321068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma digitalislike activity in essential hypertension or end-stage renal disease.
    Deray G; Pernollet MG; Devynck MA; Zingraff J; Touam A; Rosenfeld J; Meyer P
    Hypertension; 1986 Jul; 8(7):632-8. PubMed ID: 3013777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic hypertension in the SHR rat and circulating digitalis compounds].
    Wauquier I; Pernollet MG; Grichois ML; Meyer P; Devynck MA
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):982-6. PubMed ID: 2821951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the endogenous Na+-pump inhibitor in essential hypertension and blood volume expansion.
    Devynck MA; Pernollet MG; Deray G; Wauquier I; Delva P; Rieu M; Henning G; Cloix JF; Crabos M; Baudouin-Legros M
    J Hypertens Suppl; 1984 Dec; 2(3):S453-5. PubMed ID: 6100747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma sodium pump inhibitor in essential hypertension and normotensive subjects with hypertensive heredity.
    de Thé H; Devynck MA; Rosenfeld J; Pernollet MG; Elghozi JL; Meyer P
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S49-54. PubMed ID: 6204159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous digitalis-like compound in essential hypertension.
    Devynck MA; Pernollet MG; De The H; Rosenfeld JB; Meyer P
    Proc Eur Dial Transplant Assoc; 1983; 20():489-95. PubMed ID: 6318222
    [No Abstract]   [Full Text] [Related]  

  • 9. Examination of the ouabain-sensitive Na-K pump in essential hypertensive children of normal body weight.
    Koltai G; Aranyi Z; Czinner A
    Acta Paediatr Hung; 1985; 26(4):289-95. PubMed ID: 2420344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma volume expansion increases lysophosphatidylcholine and digitalis-like activity in rat plasma.
    Rauch AL; Buckalew VM
    Life Sci; 1988; 42(12):1189-97. PubMed ID: 2831443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma ouabain-like properties in hypertension and volume expansion.
    Devynck MA; Pernollet MG; Deray G; Rieu M; Meyer P
    Klin Wochenschr; 1985; 63 Suppl 3():91-3. PubMed ID: 3999654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cation transport functions in vitro in patients with untreated essential hypertension: a comparison of erythrocytes and leucocytes.
    Boon NA; Harper C; Aronson JK; Grahame-Smith DG
    Clin Sci (Lond); 1985 May; 68(5):511-5. PubMed ID: 3979014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte 3H-ouabain binding and digitalis treatment in ethanol addicted patients.
    Battaini F; Govoni S; Mauri A; Civelli L; Trabucchi M
    Life Sci; 1987 Jun; 40(26):2505-9. PubMed ID: 2885700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulating inhibitor of the Na+-K+ pump in essential hypertension. Physiological and pharmacological variations].
    Pernollet MG; de Thé H; Delva P; Wauquier I; Devynck MA; Baudouin-Legros M; Deray G; Rosenfeld J; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1283-7. PubMed ID: 6098238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma endogenous sodium pump inhibitor in essential hypertension.
    Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
    J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium pump inhibitor in the serum of patients with essential hypertension and its partial purification from hemofiltrate.
    Kuske R; Moreth K; Renner D; Wizemann V; Schoner W
    Klin Wochenschr; 1987; 65 Suppl 8():53-9. PubMed ID: 2439745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium transport by leucocytes and erythrocytes in hypertensive subjects and their normotensive relatives.
    Gray HH; Johnson VE; Poston L; Hilton PJ
    J Hypertens Suppl; 1984 Dec; 2(3):S467-9. PubMed ID: 6599701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race, sex, and family history of hypertension and erythrocyte sodium pump [3H]ouabain binding.
    Songu-Mize E; Alpert BS; Willey ES
    Hypertension; 1990 Feb; 15(2):146-51. PubMed ID: 2154403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and erythrocyte cations and permeability of the erythrocyte membrane to cations in essential hypertension.
    Aderounmu AF; Salako LA
    Afr J Med Med Sci; 1979; 8(1-2):45-9. PubMed ID: 122331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible inhibition of leucocyte sodium pumps by a circulating serum factor in essential hypertension.
    Oh VM; Taylor EA
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1551-5. PubMed ID: 2424543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.